The standard initial treatment regimen for tuberculosis (TB) typically consists of four drugs: Isoniazid (H), Rifampin (R), Pyrazinamide (Z), and Ethambutol (E). This combination is often abbreviated as HRZE.
The question asks to identify the drug that is NOT recommended for the initial treatment of tuberculosis among the options provided.
Based on the standard treatment guidelines, Ethionamide is the exception.
A 65-year old man, on Warfarin treatment, is started on antitubercular treatment. The pharmacologic effect of Warfarin is likely to:
The most frequent adverse reaction of significance among people treated for drug-susceptible tuberculosis is:
All adult patients in whom anti-tubercular treatment is being started should undergo baseline assessment of: